WATERTOWN, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that Armon Sharei, PhD, founder and chief executive officer, will present a corporate overview at the Cowen & Company 39th Annual Health Care Conference, and the Oppenheimer & Co. 29th Annual Healthcare Conference in March.
| Cowen & Company 39th Annual Health Care Conference | |
| Date: | Tuesday, March 12 |
| Time: | 1:00pm Eastern Time |
| Oppenheimer & Co. 29th Annual Healthcare Conference | |
| Date: | Tuesday, March 19 |
| Time: | 2:45pm Eastern Time |
About SQZ Biotech
SQZ Biotech is a privately held company creating innovative treatments by transforming cells into sophisticated therapeutics. Using its proprietary platform, SQZ has the unique ability to precision engineer any cell type and deliver multiple materials, resulting in powerful, multifunctional cell therapies for a range of diseases with an initial focus on cancer and autoimmune disease. The first applications for the company leverage SQZ’s ability to generate target-specific immune responses, both in activation for the treatment of solid tumors, and immune suppression for the treatment of auto-immune diseases. For more information please visit www.sqzbiotech.com.
SQZ Contact:
Rebecca Cohen
Senior Manager, Corporate Relations
rebecca.cohen@sqzbiotech.com
617-758-8672 ext. 728
Media Contact
Cait Williamson, PhD
LifeSci Public Relations
cait@lifescipublicrelations.com
646-751-4366